Literature DB >> 12716688

Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study.

Floor V A van Oort1, Alida Melse-Boonstra, Ingeborg A Brouwer, Robert Clarke, Clive E West, Martijn B Katan, Petra Verhoef.   

Abstract

BACKGROUND: Elevated homocysteine concentrations, a likely risk factor for cardiovascular disease, can be lowered effectively with folic acid. The minimum dose of folic acid required for maximal reduction of homocysteine concentrations is not yet known reliably.
OBJECTIVE: We aimed to determine the lowest folic acid dose that decreases plasma homocysteine concentrations adequately in healthy older adults.
DESIGN: A dose-response trial with a randomized, double-blind, parallel-group, placebo-controlled design was carried out among 316 Dutch men and women aged 50-75 y. Subjects received daily for 12 wk either a placebo or 1 of the 6 following folic acid doses: 50, 100, 200, 400, 600, or 800 micro g. The relative changes in plasma homocysteine concentration in response to increasing doses of folic acid were used to calculate the dose-response curve. An adequate dose of folic acid was defined as the dose that induced >or= 90% of the maximal reduction in homocysteine concentration.
RESULTS: The relative decrease in plasma homocysteine concentration was associated exponentially with increasing doses of folic acid. From the dose-response curve, the adequate daily dose of folic acid was estimated to be 392 micro g, which decreased plasma homocysteine concentrations 22%.
CONCLUSION: In older adults, daily supplementation with folic acid effectively lowers plasma homocysteine concentrations, and a daily dose of approximately 400 micro g is the minimum dose required for adequate homocysteine reduction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716688     DOI: 10.1093/ajcn/77.5.1318

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  18 in total

Review 1.  Periconceptional folic acid fortification for the risk of gestational hypertension and pre-eclampsia: a meta-analysis of prospective studies.

Authors:  Xiaorong Yang; Hui Chen; Yihui Du; Shuting Wang; Zhiping Wang
Journal:  Matern Child Nutr       Date:  2015-08-11       Impact factor: 3.092

2.  Betaine supplementation decreases plasma homocysteine in healthy adult participants: a meta-analysis.

Authors:  Marc P McRae
Journal:  J Chiropr Med       Date:  2013-03

3.  A prospective study of shortened vitamin supplementation prior to cisplatin-pemetrexed therapy for non-small cell lung cancer.

Authors:  Yusuke Takagi; Yukio Hosomi; Kuniko Sunami; Yoshiro Nakahara; Yusuke Okuma; Makiko Yomota; Tsuneo Shimokawa; Makoto Nagamata; Mari Iguchi; Hiroaki Okamoto; Tatsuru Okamura; Masahiko Shibuya
Journal:  Oncologist       Date:  2014-09-26

4.  Impact of voluntary folate fortification on plasma homocysteine and serum folate in Australia from 1995 to 2001: a population based cohort study.

Authors:  Siobhan Hickling; Joseph Hung; Matthew Knuiman; Konrad Jamrozik; Brendan McQuillan; John Beilby; Peter Thompson
Journal:  J Epidemiol Community Health       Date:  2005-05       Impact factor: 3.710

5.  Effect of losartan with folic acid on plasma homocysteine and vascular ultrastructural changes in spontaneously hypertensive rats.

Authors:  Lihe Zhu; Jiong Yu; Baofu Jia; Feng Zhao; Mengmeng Tang; Lufeng Hu; Feiyan Lin
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 6.  Perinatal folate supply: relevance in health outcome parameters.

Authors:  Katalin Fekete; Cristiana Berti; Irene Cetin; Maria Hermoso; Berthold V Koletzko; Tamás Decsi
Journal:  Matern Child Nutr       Date:  2010-10       Impact factor: 3.092

7.  Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma.

Authors:  Ozgül Altintaş; Hale Maral; Nurşen Yüksel; V Levent Karabaş; Meltem O Dillioğlugil; Yusuf Cağlar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-02-02       Impact factor: 3.117

8.  Effects of folic acid supplementation on serum folate and plasma homocysteine concentrations in older adults: a dose-response trial.

Authors:  Cheryl A M Anderson; Sun Ha Jee; Jeanne Charleston; Matthew Narrett; Lawrence J Appel
Journal:  Am J Epidemiol       Date:  2010-09-16       Impact factor: 4.897

9.  A Daily Dose of 5 mg Folic Acid for 90 Days Is Associated with Increased Serum Unmetabolized Folic Acid and Reduced Natural Killer Cell Cytotoxicity in Healthy Brazilian Adults.

Authors:  Clovis Paniz; Juliano Felix Bertinato; Maylla Rodrigues Lucena; Eduardo De Carli; Patrícia Mendonça da Silva Amorim; Guilherme Wataru Gomes; Cecília Zanin Palchetti; Maria Stella Figueiredo; Christine M Pfeiffer; Zia Fazili; Ralph Green; Elvira Maria Guerra-Shinohara
Journal:  J Nutr       Date:  2017-07-19       Impact factor: 4.798

10.  Effect of genetic polymorphisms involved in folate metabolism on the concentration of serum folate and plasma total homocysteine (p-tHcy) in healthy subjects after short-term folic acid supplementation: a randomized, double blind, crossover study.

Authors:  Rona Cabo; Sigrunn Hernes; Audun Slettan; Margaretha Haugen; Shu Ye; Rune Blomhoff; M Azam Mansoor
Journal:  Genes Nutr       Date:  2015-03-11       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.